Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Share-based Compensation (2016 - 2017)

Skinvisible (SKVI) has disclosed Share-based Compensation for 8 consecutive years, with $60456.0 as the latest value for Q4 2017.

  • Quarterly Share-based Compensation rose 391.47% to $60456.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $223090.0 through Dec 2017, up 53.07% year-over-year, with the annual reading at $223090.0 for FY2017, 53.07% up from the prior year.
  • Share-based Compensation hit $60456.0 in Q4 2017 for Skinvisible, up from $47302.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $133445.0 in Q1 2016 to a low of $3000.0 in Q2 2013.
  • Historically, Share-based Compensation has averaged $34898.9 across 5 years, with a median of $23400.0 in 2014.
  • Biggest five-year swings in Share-based Compensation: soared 1416.42% in 2016 and later crashed 82.02% in 2017.
  • Year by year, Share-based Compensation stood at $8400.0 in 2013, then surged by 178.57% to $23400.0 in 2014, then tumbled by 78.63% to $5000.0 in 2015, then soared by 146.02% to $12301.0 in 2016, then skyrocketed by 391.47% to $60456.0 in 2017.
  • Business Quant data shows Share-based Compensation for SKVI at $60456.0 in Q4 2017, $47302.0 in Q3 2017, and $91332.0 in Q2 2017.